Cell Culture Technology Weekly Report May 18, 2026

Cell Culture Technology Weekly Report July 26, 2026

Breakthroughs in iPSC and 3D Organoids Drive Stem Cell Therapies Towards Clinical Reality and Scalable Manufacturing

Sonoma Biotherapeutics Automates Autologous CAR-Treg Therapy Manufacturing for Rheumatoid Arthritis with Cellares’ Cell Shuttle Platform

FDA Clears Prime Medicine’s In Vivo Prime Editor for Wilson Disease, Setting Stage for 2027 Data

AI and Digital Twin Challenges in GMP Manufacturing: Regulators Demand Audit Trails for Continuously Learning Models

A4BEE Demonstrates Adaptive Digital Twin for Bioprocess Autonomy and Computer Vision for Non-Invasive Foam Management in Bioreactor Control

CuraCell Pursues Gentler Preconditioning and Reduced Manufacturing Costs for CC-38 TIL Therapy for Solid Tumors, Enhancing Patient Eligibility and Cost-Effectiveness

Eli Lilly Acquires Kelonia and Orna Therapeutics as Investment in In Vivo Cell Therapies Surges, Aiming to Reduce Treatment Burden and Manufacturing Costs